MELATONIN RECEPTORS MT1/MT2 IN PROINFLAMMATORY T-HELPER POPULATIONS



Cite item

Full Text

Abstract

Abstract

Objective. The pineal hormone melatonin is an effective regulator of the main T helper populations Th1 and Th17. Currently, the focus of attention in the study of T helpers is shifting from classical to non-classical variants of these cells, primarily to Th1-polarized lymphocytes Th17 (Th17.1), which are formed in vitro and in vivo by transforming differentiated Th17 cells into Th1 under polarizing conditions. Th17.1 cells have a significantly higher pro-inflammatory potential compared to classical Th1/Th17 and play a key role in the pathogenesis of Th-dependent pro-inflammatory diseases, including autoimmune diseases. Tasks. This shift in priorities in the study of T helper activity raises the question of the sensitivity of non-classical pathogenic CD4+Т lymphocytes to melatonin-dependent regulation, which is largely determined by the expression of high-affinity receptors for the hormone, MT1 and MT2, on the cell membrane. Materials and methods. In this work, we studied the expression of MT1 and MT2 by proinflammatory T-helper populations of peripheral blood. Results. It was shown that non-classical Th1-polarized Th17 cells have a selectively high level of expression of these receptors, which makes them a priority target for the action of melatonin. Discussion and conclusions. It is important to note that MT1 and MT2 exert their effects primarily through inhibitory G proteins (Gi), suppressing adenylate cyclase activity, and, to a lesser extent, through Gq and Go proteins, activating phospholipase C, calcium channels, and mitogen-activated protein kinases. Moreover, all of the listed signaling pathways, launched when melatonin binds to membrane melatonin receptors, are stimulating or costimulating for T cells. In this regard, it is logical to expect a stimulatory effect of melatonin on the pathogenic Th17.1 population. However, melatonin has not only a membrane but also a nuclear receptor, RORα (an obligate molecule for Th17 cells – both classical and non-classical), and at micromolar concentrations is able to bind to additional intracellular targets, such as calmodulin or hydroquinone, and trigger other signaling mechanisms that can correct MT1/MT2-dependent signals.

Keywords

About the authors

Elena Michajlovna Kuklina

Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center, Ural Branch, Russian Academy of Sciences, Perm, Russian Federation

Email: ibis_07@mail.ru
ORCID iD: 0000-0002-2173-2724

Dr. Sc, (Biol.), Leading Research Officer at the Laboratory of Immunoregulation

Russian Federation, 13, Golev str., Perm, 614081, Russia

Irina Yuryevna Danchenko

E. Wagner Perm State Medical University, Perm, Russian Federation

Email: irene-dan@mail.ru
ORCID iD: 0000-0002-3145-5409

Candidate of Medicine, Assistant of the Department of Neurology and Medical Genetics

Russian Federation, 26, Petropavlovskaya str., Perm, 614990, Russia

Tatiana Vitalievna Baidina

E. Wagner Perm State Medical University, Perm, Russian Federation

Author for correspondence.
Email: tatiana_baidina@mail.ru
ORCID iD: 0000-0002-5114-0463

Professor, Department of Neurology and Medical Genetics

Russian Federation, 26, Petropavlovskaya str., Perm, 614990, Russia

References

  1. Kuklina E.M., Glebezdina N.S., Nekrasova I.V. Role of Melatonin in the Regulation of Differentiation of T Cells Producing Interleukin-17 (Th17). Bull. Exp. Biol. Med., 2016, Vol. 160, no. 5, pp. 656–658. doi: 10.1007/s10517-016-3242-4
  2. Carrillo-Vico A., Garcia-Maurino S., Calvo J.R., Guerrero J.M. Melatonin Counteracts the Inhibitory Effect of PGE2 on IL-2 Production in Human Lymphocytes via Its Mt1 Membrane Receptor. FASEB J., 2003, Vol. 17, pp. 755–757. doi: 10.1096/fj.02-0501fje.
  3. Cecon E., Oishi A., Jockers R. Melatonin Receptors: Molecular Pharmacology and Signalling in the Context of System Bias. Br. J. Pharm., 2018, Vol. 175, pp. 3263–3280. doi: 10.1111/bph.13950.
  4. Chang T., Niu C., Sun C., Ma Y., Guo R., Ruan Z., Gao Y., Lu X., Li H., Lin Y., Lin J., Li Z. Melatonin exerts immunoregulatory effects by balancing peripheral effector and regulatory T helper cells in myasthenia gravis. Aging (Albany NY), 2020, Vol. 12, no. 21, pp. 21147–21160. doi: 10.18632/aging.103785.
  5. Drazen D.L., Bilu D., Bilbo S.D., Nelson R.J. Melatonin Enhancement of Splenocyte Proliferation Is Attenuated by Luzindole, a Melatonin Receptor Antagonist. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2001, Vol. 280, pp. R1476–R1482. doi: 10.1152/ajpregu.2001.280.5.R1476.
  6. Dubocovich M.L., Delagrange P., Krause D.N., Sugden D., Cardinali D.P., Olcese J. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors. Pharm. Rev., 2010, Vol. 62, pp. 343–380. doi: 10.1124/pr.110.002832.
  7. Farez M.F., Mascanfroni I.D., Mendez-Huergo S.P., Yeste A., Murugaiyan G., Garo L.P., Balbuena Aguirre M.E., Patel B., Ysrraelit M.C., Zhu C., Kuchroo V.K., Rabinovich G.A., Quintana F.J., Correale J. Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses. Cell, 2015, Vol. 162, no. 6, pp. 1338–1352. doi: 10.1016/j.cell.2015.08.025.
  8. Garcia-Maurino S., Gonzalez-Haba M.G., Calvo J.R., Rafii-El-Idrissi M., Sanchez-Margalet V., Goberna R., Guerrero J.M. Melatonin enhances IL-2, IL-6 and IFNγ production by human circulating CD 4+ cells: A posible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J. Immunol., 1997, Vol. 159, no. 2, pp. 574–581.
  9. Garcia-Maurino S., Pozo D., Carrillo-Vico A., Calvo J.R., Guerrero J.M. Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci. 1999, Vol. 65, pp. 2143–2150. doi: 10.1016/s0024-3205(99)00479-8.
  10. Garcia-Perganeda A., Pozo D., Guerrero J.M., Calvo J.R. Signal Transduction for Melatonin in Human Lymphocytes: Involvement of a Pertussis Toxin-Sensitive G Protein. J. Immunol., 1997, Vol. 159, no. 8, pp. 3774–3781.
  11. Nikolaev G., Robeva R., Konakchieva R. Membrane Melatonin Receptors Activated Cell Signaling in Physiology and Disease. Int. J. Mol. Sci., 2021, Vol. 23, no. 1, pp. 471. doi: 10.3390/ijms23010471.
  12. Quirant-Sanchez B., Presas-Rodriguez S., Mansilla M.J., Teniente-Serra A., Hervas-Garcia J.V., Brieva L., Moral-Torres E, Cano A, Munteis E, Navarro-Barriuso J, Martinez-Caceres EM, Ramo-Tello C. Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment. Mediators Inflamm. 2019, Vol. 2019, pp. 8147803. doi: 10.1155/2019/8147803.
  13. Ramstein J., Broos C.E., Simpson L.J., Ansel K.M., Sun S.A., Ho M.E., Woodruff P.G., Bhakta N.R., Christian L., Nguyen C.P., Antalek B.J., Benn B.S., Hendriks R.W., van den Blink B., Kool M., Koth L.L. IFN-γ–Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 Cells. Am. J. Respir. Crit. Care. Med., 2016, Vol. 193, no. 11, pp. 1281–1291. doi: 10.1164/rccm.201507-1499OC.
  14. Schnell A., Littman D.R., Kuchroo V.K. TH17 Cell Heterogeneity and Its Role in Tissue Inflammation. Nat. Immunol., 2023, Vol. 24, pp. 19–29. doi: 10.1038/s41590-022-01387-9.
  15. Thakore P.I., Schnell A., Zhao M., Huang L., Hou Y., Christian E., Zaghouani S., Wang C., Singh V., Ma S., Sankar V., Notarbartolo S., Buenrostro J.D., Sallusto F., Patsopoulos N.A., Rozenblatt-Rosen O., Kuchroo V.K., Regev A. The Chromatin Landscape of Th17 Cells Reveals Mechanisms of Diversification of Regulatory and Pro-Inflammatory States. BioRxiv., 2002, pp. 2022.02.26.482041. doi: 10.1101/2022.02.26.482041.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Kuklina E.M., Danchenko I.Y., Baidina T.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies